A1 Refereed original research article in a scientific journal

Global Incidence of Pertussis After the COVID-19 Pandemic




AuthorsGorringe, Andrew; Cavell, Breeze; Beard, Frank; Tsukada, Keiko; Otsuka, Nao; Fu, Pan; Moosa, Fahima; Fabianova, Katerina; Rodrigues, Carla; Bouchez, Valerie; Toubiana, Julie; Brisse, Sylvain; Dalby, Tine; He, Qiushui; Campbell, Helen; Hozbor, Daniela; Hariri, Susan; Pawloski, Lucia; Scanlon, Karen; Edwards, Kathryn

PublisherJAMA Network

Publication year2025

Journal: JAMA Network Open

Article numbere2545963

Volume8

Issue12

eISSN2574-3805

DOIhttps://doi.org/10.1001/jamanetworkopen.2025.45963

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Open Access publication channel

Web address https://doi.org/10.1001/jamanetworkopen.2025.45963

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/505793239


Abstract

Importance  Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants.

Observations  In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries.

Conclusions and Relevance  The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
The sponsor of this work was the International Bordetella Society, and the work was led by several members of the society. No additional funding was provided to the presenters for this work.


Last updated on 15/12/2025 11:49:05 AM